Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.090
+0.060 (2.96%)
At close: Oct 5, 2026, 4:00 PM EDT
2.100
+0.010 (0.48%)
After-hours: Oct 5, 2026, 7:30 PM EDT

Fortress Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
70114565571249
Market Cap Growth
-8.53%103.22%2.43%-23.29%-71.44%-17.12%
Enterprise Value
-74105352628219
Last Close Price
2.033.662.023.019.8237.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
2.700.610.61---
PS Ratio
1.021.800.970.650.943.62
PB Ratio
0.411.83-34.0034.391.421.10
P/TBV Ratio
0.505.10-24.214.902.59

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-1.660.600.310.373.18

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.261.08-46.2055.822.590.33
Net Debt / Equity Ratio
-0.69-0.20-11.374.83-0.98-1.02
Net Debt / EBITDA Ratio
5.740.19-0.18-0.060.251.33
Net Debt / FCF Ratio
-1.140.19-0.23-0.060.271.91
Asset Turnover
0.290.380.370.370.220.19
Inventory Turnover
2.392.736.3110.5913.7928.57
Quick Ratio
3.762.200.951.131.623.26
Current Ratio
3.962.491.271.381.803.43
Return on Equity (ROE)
115.98%-108.74%--597.36%-155.06%-77.95%
Return on Assets (ROA)
-7.76%-26.62%-42.78%-36.83%-36.84%-30.65%
Return on Capital Employed (ROCE)
-11.60%-51.70%-146.50%-164.70%-122.20%-60.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
148.30%6.00%-82.28%-111.11%-121.69%-25.98%
FCF Yield
180.54%-57.90%-143.45%-235.07%-255.99%-48.62%
Buyback Yield / Dilution
-25.98%-34.24%-156.25%-36.89%-8.78%-13.46%
SEC Filings: 10-K · 10-Q